R
Rocket Pharmaceuticals
Cranbury, United States
Founded 2015 NASDAQ: RCKT
About
Lentiviral and AAV gene therapies for rare diseases
Company Details
- Type
- public
- Employees
- 300+
- Funding
- Public
Key Products
- RP-L201
- Gene Therapy
Lentiviral and AAV gene therapies for rare diseases